Quality Investor

Plexus Corp.

Rank #441Capital Return

PLXS · Nasdaq · Technology

Plexus Corp. (PLXS) — Rank #441 by gross profitability (GP/assets 0.11) · ROE 11.3% · Piotroski F-Score N/A.

As-of 2026-09-15 · CIK 0000785786 · all metrics point-in-time as of the filing date.

About

Plexus Corp. provides electronic manufacturing services in the United States, the Asia-Pacific, Europe, the Middle East, and Africa.

Show more

The company offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services. It serves the aerospace/defense, healthcare/life sciences, and industrial/commercial sectors. Plexus Corp.

was founded in 1979 and is headquartered in Neenah, Wisconsin.

Industry
Electronic Components
Sector
Technology
State
WI
Filer Category
Large accelerated filer
Fiscal Year End
October 3
Website
plexus.com

Price History

PLXS+180.9% · +22.9% CAGRSPY+80.5% · +12.5% CAGR

Company Snapshot

P/E and reverse DCF are the primary valuation lenses at this stage.

Market Cap

$6.33B

P/E (annual)

37.9

P/S (annual)

1.6

P/B

4.1

P/OCF (annual)

25.4

Shareholder Yield

20.9%

Employees

20,000

Industry

Electronic Components

Exchange

Nasdaq

Signal Flags

2 green1 red
Operating leverage expandingOperating income growing faster than revenue
Sequential beat (rev + EPS)Both revenue and EPS exceeded prior quarter — 2-quarter streak
Revenue declining YoYRevenue contracted year over year

Quality Profile

Profitability

GP / assets
0.11
Return on equity
11.3%
Gross margin trend
N/A

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
1.38
Current ratio
1.49×
Net cash
$314.05M

Cash Flow

2/3 pass
Positive FCF
PASS
Cash-backed earnings
WARN
Accruals healthy
PASS
SBC / revenue
0.8%

Growth

1/2 pass
Revenue growth
-3993.1%
Piotroski F-Score
N/A
Share dilution
-20.9%

Terry Smith quality gate

Passes 1/5 Terry Smith thresholds

What Growth Is Priced In

Implied revenue growth (10Y)

18.0%

fairly valued

The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).

Buyback tailwind: -20.9% — per-share value needs a total required return of -2.9% once share-count change is priced in.

vs. own 6-year median revenue growth: -33.1%

Cost-of-equity sensitivity (implied growth at different discount rates)

r = 8%

13.1%

r = 10% (base)

18.0%

r = 12%

22.2%

Net debt / market cap: -4.8%

Base FCF: $154M3Y mean FCF: $74.1M

Valuation History

Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.

P / E

Price / diluted EPS

19.2xFair
12.7xmed 18.8x23.7x

P / S

Price / revenue per share

0.8xExpensive
0.6xmed 0.7x0.8x

P / B

Price / book value per share

2.6xExpensive
1.7xmed 2.1x2.7x

P / GP

Price / gross profit per share

8.2xExpensive
5.5xmed 7.1x8.2x

P / FCF

Price / free cash flow per share

31.1xFair
9.7xmed 16.1x95.6x

FCF yield, shareholder yield, and buyback activity are the primary reads at this stage.

Profitability

Gross profitability (GP / assets)

0.11

Primary signal (Novy-Marx).

5th pctl of 43 SIC 36 peers

Return on equity

11.3%

Gross margin

10.1%

2nd pctl of 43 SIC 36 peers

Revenue growth (YoY)

-3993.1%

Gross margin improving

Margin trend vs prior year.

N/A

Operating Leverage

2013201420202021
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

Revenue CAGR (5Y)

2.9%

Earnings CAGR (3Y)

7.7%

FCF CAGR (3Y)

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

1.38

12th pctl of 41 SIC 36 peers (best = lowest)

Current ratio

1.49×

5th pctl of 43 SIC 36 peers

Quick ratio

0.57×

Net cash

$314.05M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$153.97M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

-0.11

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

WARN

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.8%

Stock-based comp intensity.

Piotroski F-Score

F-Score

N/A

Only 7/9 components determinable.

Lifecycle Phase History

20112021
Decline
Value
Capital Return